Abbott Laboratories (ABT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Abbott Laboratories, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 33.55x | 14.62x | 33.35x | 27.76x | 35.33x | 43.19x |
| P/B Ratio | 4.20x | 4.11x | 4.94x | 5.25x | 6.98x | 5.92x |
| P/S Ratio | 4.94x | 4.67x | 4.76x | 4.41x | 5.80x | 5.61x |
| Profitability | ||||||
| Gross Margin | 55.5% | 50.8% | 50.0% | 51.1% | 53.9% | 50.2% |
| Operating Margin | 18.2% | 16.3% | 16.0% | 19.2% | 21.4% | 15.3% |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% |
| EBITDA Margin | 26.1% | 25.8% | 26.4% | 27.2% | 28.2% | 26.0% |
| Liquidity | ||||||
| Current Ratio | 1.58x | 1.67x | 1.64x | 1.63x | 1.85x | 1.72x |
| Quick Ratio | 1.18x | 1.23x | 1.16x | 1.23x | 1.46x | 1.30x |
| Leverage | ||||||
| Debt/Equity | 0.29x | 0.32x | 0.41x | 0.49x | 0.54x | 0.61x |
YoY = year-over-year change. Source: FMP..